Redefining female reproductive health.

Gameto is a biotechnology company using cell engineering to develop novel therapeutics

We aim to solve diseases of the female reproductive system

Women's health has been a neglected area.

Most conditions have few treatment options, and those available often cause frequent complications and offer minimal benefit.

But we have developed a cell engineering platform to change that.

Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. With this platform, we can develop therapeutics to cure diseases that affect many.

Solving diseases of the female reproductive system

We are committed to using cellular engineering to improve lives. We are advancing a pipeline of cell therapies that target devastating diseases and contribute to reproductive health research.

Scientists, Innovators, and Biotechnology Entrepreneurs

We are a passionate, kind, and collaborative team.
Our mission to redefine female reproductive health guides everything we do.

Find out how to join us.

Latest news

News

Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women's Health

News

Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine

Scientific Publications

Towards reconstituting an ovary

News

34 of the most promising women's health startups of 2022, according to VCs

News

Llega a España Gameto, la startup biotecnológica que emplea ingeniería celular para hacer frente al deterioro ovárico

News

Varsavsky elige Madrid para los estudios preclínicos en Europa de su startup Gameto

News

Biotech Startup Gameto on Female Fertility and Aging

News

Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics

Scientific Publications

Efficient Human Germ Cell Specification from Stem Cells via Combinatorial Expression of Transcription Factors

Scientific Publications

Directed Differentiation of Human iPSCs to Functional Ovarian Granulosa-Like Cells via Transcription Factor Overexpression

News

Is it Time to Cancel Menopause?

News

The 20(+1) under 40: Your guide to the next generation of biotech leaders

News

Why aren’t VCs funding more startups focused on menopause?

Scientific Publications

Expanding homogeneous culture of human primordial germ cell-like cells maintaining germline features without serum or feeder layers

News

International Women’s Day: the wonderful women of longevity

News

Gameto founder talks menopause and female healthspan extension Copy

News

Nature Is Sexist. Can Advances In Longevity Biotechnology Help Restore Reproductive Equality? Copy

News

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells

Scientific Publications

An integrated pipeline for mammalian genetic screening

We make products & therapies that people love.